冈比亚队列中B组链球菌功能性抗体与母婴定植的关联
在750对母婴中,采用抗体介导C3b/iC3b沉积流式细胞术检测脐血和婴儿血清,发现母源性抗GBS功能性抗体越高,婴儿出生时及生后60-89天内定植越少;STII、STIII、STV存在无婴儿定植的血清型依赖阈值,抗体升高也与GBS清除相关。
要点
- 母源性抗GBS功能性抗体增加与婴儿出生时及生后60-89天定植减少相关。
- STII、STIII、STV存在血清型依赖阈值,高于该阈值时无婴儿出生时定植。
- 功能性抗体高于几何平均浓度95%置信区间上限与STII、STIII、STV出生时无定植相关。
核心结论
- 较高浓度的母源性抗体介导补体沉积与婴儿生后60-89天内GBS定植风险降低相关。
- 该发现对未来GBS疫苗孕妇接种后保护阈值的建立具有相关性。
研究设计与样本
- 研究纳入750对母亲/婴儿,采集产时直肠阴道拭子和脐血,以及婴儿出生、第6天和第60-89天的鼻咽/直肠拭子。
- 采用流式细胞术检测脐血和婴儿血清的抗体介导C3b/iC3b沉积。
主要发现
- 母源性抗GBS功能性抗体增加时,婴儿出生时及生后至三个月(GBS疾病关键时间窗)定植减少。
- 观察到血清型(ST)依赖阈值,高于该阈值时无婴儿在出生时定植。
- 功能性抗体高于几何平均浓度95%置信区间上限与STII(p<0.001)、STIII(p=0.01)、STV(p<0.001)婴儿出生时无GBS定植相关。
- 功能性抗体增加也与出生至第60-89天期间GBS清除相关。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vertical transmission of Group B Streptococcus (GBS) is a prerequisite for early-onset disease and a consequence of maternal GBS colonization. Disease protection is associated with maternally-derived anti-GBS antibody. Using a novel antibody-mediated C3b/iC3b deposition flow cytometry assay which correlates with opsonic killing we developed a model to assess the impact of maternally-derived functional anti-GBS antibody on infant GBS colonization from birth to day 60-89 of life. METHODS: Rectovaginal swabs and cord blood (birth) and infant nasopharyngeal/rectal swabs (birth, day 6 and day 60-89) were obtained from 750 mother/infant pairs. Antibody-mediated C3b/iC3b deposition with cord and infant sera was measured by flow cytometry. RESULTS: We established that as maternally-derived anti-GBS functional antibody increases, infant colonization decreases at birth and up to three months of life, the critical time window for the development of GBS disease. Further, we observed a serotype (ST)-dependent threshold above which no infant was colonized at birth. Functional antibody above the upper 95th confidence interval for the geometric mean concentration was associated with absence of infant GBS colonization at birth for STII (p<0.001), STIII (p=0.01) and STV (p<0.001). Increased functional antibody was also associated with clearance of GBS between birth and day 60-89. CONCLUSIONS: Higher concentrations of maternally-derived antibody-mediated complement deposition are associated with a decreased risk of GBS colonization in infants up to day 60-89 of life. Our findings are of relevance to establish thresholds for protection following vaccination of pregnant women with future GBS vaccines.
引用
- Le Doare K, Faal A, Jaiteh M, et al. Association between functional antibody against Group B Streptococcus and maternal and infant colonization in a Gambian cohort. Vaccine. 2017. PMID: 28449969. doi:10.1016/j.vaccine.2017.04.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。